84年鼠女哪年财运最旺,857comvvv色九欧美激情|85PO_87国产精品欲av国产av资源

[1]林煜,張怡元,馮爾宥,等.人參皂甙Rg1與鈦微粒對大鼠顱骨成骨細(xì)胞的影響[J].中醫(yī)正骨,2013,25(07):8-15.
 LIN Yu*,ZHANG Yi-yuan,FENG Er-you,et al.Effect of Ginsenoside Rg1 and titanium particles on rat cranioaural osteoblasts[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2013,25(07):8-15.
點擊復(fù)制

人參皂甙Rg1與鈦微粒對大鼠顱骨成骨細(xì)胞的影響()
分享到:

《中醫(yī)正骨》[ISSN:1001-6015/CN:41-1162/R]

卷:
第25卷
期數(shù):
2013年07期
頁碼:
8-15
欄目:
基礎(chǔ)研究
出版日期:
2013-07-31

文章信息/Info

Title:
Effect of Ginsenoside Rg1 and titanium particles on rat cranioaural osteoblasts
作者:
林煜1張怡元1馮爾宥1吳銀生2林燕萍2
1.廈門大學(xué)附屬福州第二醫(yī)院,福建 福州 350007; 2.福建中醫(yī)藥大學(xué)中西醫(yī)結(jié)合研究院,福建 福州 350108
Author(s):
LIN Yu*ZHANG Yi-yuanFENG Er-youWU Yin-shengLIN Yan-ping.*
The second hospital of Fuzhou affiliated to Xiamen University,Fuzhou 350007,China
關(guān)鍵詞:
成骨細(xì)胞 細(xì)胞培養(yǎng)技術(shù) 人參皂甙 細(xì)胞因子類 環(huán)氧化酶2 鈦 人工關(guān)節(jié)
Keywords:
Osteoblasts Cell culture techniques Ginsenoside Cytokines Cyclooxygenase 2 Titanium Joint prosthesis
摘要:
目的:探討人參皂甙Rg1與鈦微粒對大鼠顱骨成骨細(xì)胞的影響,為人工關(guān)節(jié)假體松動的防治提供新思路。方法:收集、純化新生SD大鼠顱骨成骨細(xì)胞,篩選鈦微粒,配制鈦微粒浸提液,進(jìn)行內(nèi)毒素檢測后,將培養(yǎng)的第3代成骨細(xì)胞以1×105個·mL-1的密度傳代接種于5組培養(yǎng)液中,即正常組(含10%胎牛血清的DMEM培養(yǎng)基)、鈦微粒組(體積比為0.1%的鈦微粒混懸液+含10%胎牛血清的DMEM培養(yǎng)基)、鈦+高Rg1組(體積比為0.1%的鈦微粒混懸液+終濃度為100 μg·m-1的人參皂苷Rg1+含10%胎牛血清的DMEM培養(yǎng)基)、鈦+中Rg1組(體積比為0.1%的鈦微粒混懸液+終濃度為50 μg·m-1的人參皂苷Rg1+含10%胎牛血清的DMEM培養(yǎng)基)、鈦+低Rg1組(體積比為0.1%的鈦微粒混懸液+終濃度為25 μg·m-1的人參皂苷Rg1+含10%胎牛血清的DMEM培養(yǎng)基)。連續(xù)培養(yǎng)24 h后,觀察成骨細(xì)胞形態(tài); 采用酶聯(lián)免疫吸附法檢測細(xì)胞培養(yǎng)液中前列腺素E2、腫瘤壞死因子α、白細(xì)胞介素6、白細(xì)胞介素1及白細(xì)胞介素1受體拮抗劑的濃度; 采用實時熒光定量法檢測成骨細(xì)胞中環(huán)氧化酶2mRNA、腫瘤壞死因子αmRNA的表達(dá); 采用Western Blotting法檢測成骨細(xì)胞中環(huán)氧化酶2蛋白的表達(dá)。結(jié)果:5組成骨細(xì)胞培養(yǎng)液前列腺素E2光密度值的差異有統(tǒng)計學(xué)意義(F=244.895,P=0.000); 鈦微粒組、鈦+高Rg1組、鈦+中Rg1組均高于正常組[(53.362±0.307),(41.048±0.431),(38.998±0.234),(31.687±0.466),P=0.000,P=0.000,P=0.000]; 鈦+高Rg1組、鈦+中Rg1組、鈦+低Rg1組(32.501±0.124)均低于鈦微粒組(P=0.000,P=0.000,P=0.000); 鈦+低Rg1組低于鈦+高Rg1組、鈦+中Rg1組(P=0.000,P=0.000); 鈦+高Rg1組高于鈦+中Rg1組(P=0.000); 正常組與鈦+低Rg1組比較,差異無統(tǒng)計學(xué)意義(P=0.168)。5組成骨細(xì)胞培養(yǎng)液腫瘤壞死因子α光密度值的差異有統(tǒng)計學(xué)意義(F=72.340,P=0.000); 鈦微粒組、鈦+高Rg1組、鈦+中Rg1組、鈦+低Rg1組均高于正常組[(50.121±0.532),(49.675±0.336),(46.431±0.245),(42.521±0.513),(40.055±0.471),P=0.000,P=0.000,P=0.000,P=0.001]; 鈦+中Rg1組、鈦+低Rg1組低于鈦微粒組(P=0.000,P=0.000); 鈦+低Rg1組低于鈦+高Rg1組、鈦+中Rg1組(P=0.000,P=0.000); 鈦+高Rg1組高于鈦+中Rg1組(P=0.000); 鈦微粒組與鈦+高Rg1組比較,差異無統(tǒng)計學(xué)意義(P=0.230)。5組成骨細(xì)胞培養(yǎng)液白細(xì)胞介素6光密度值的差異有統(tǒng)計學(xué)意義(F=80.449,P=0.000); 鈦微粒組、鈦+高Rg1組、鈦+中Rg1組、鈦+低Rg1組均高于正常組[(80.537±0.883),(70.975±0.945),(68.154±0.745),(63.335±0.845),(57.550±0.610),P=0.000,P=0.000,P=0.000,P=0.000]; 鈦+高、中、低Rg1組均低于鈦微粒組(P=0.000,P=0.000,P=0.000); 鈦+低Rg1組低于鈦+高、中Rg1組(P=0.001,P=0.000); 鈦+高Rg1組高于鈦+中Rg1組(P=0.039)。5組成骨細(xì)胞培養(yǎng)液白細(xì)胞介素1光密度值的差異有統(tǒng)計學(xué)意義(F=38.483,P=0.000); 鈦微粒組、鈦+高Rg1組、鈦+中Rg1組、鈦+低Rg1組均高于正常組[(83.106±4.413),(59.506±1.294),(56.881±3.561),(45.081±3.459),(37.579±3.526),P=0.000,P=0.000,P=0.000,P=0.000]; 鈦+高、中、低Rg1組均低于鈦微粒組(P=0.000,P=0.000,P=0.000),鈦+低Rg1組低于鈦+高、中Rg1組(P=0.000,P=0.000),鈦+中Rg1組與鈦+高Rg1組相比,差異無統(tǒng)計學(xué)意義(P=0.187)。5組成骨細(xì)胞培養(yǎng)液白細(xì)胞介素1受體拮抗劑光密度值的差異有統(tǒng)計學(xué)意義(F=492.724,P=0.000); 鈦微粒組、鈦+高Rg1組、鈦+中Rg1組、鈦+低Rg1組均低于正常組[(64.111±1.364),(116.351±5.432),(229.768±3.545),(207.203±2.436),(268.019±3.871),P=0.000,P=0.000,P=0.000,P=0.000]; 鈦+高、中、低Rg1組均高于鈦微粒組(P=0.000,P=0.000,P=0.000),鈦+中Rg1組高于鈦+高、低Rg1組(P=0.000,P=0.000),鈦+高Rg1組低于鈦+低Rg1組(P=0.000)。5組成骨細(xì)胞中β-actin、環(huán)氧化酶2、腫瘤壞死因子α熒光定量RT-PCR部分?jǐn)U增曲線和各基因的溶解曲線表現(xiàn)為單一的溶解峰,均為特異性擴(kuò)增。5組成骨細(xì)胞環(huán)氧化酶2mRNA表達(dá)的差異有統(tǒng)計學(xué)意義(F=886.930,P=0.000); 與鈦微粒組相比,鈦+高Rg1組、鈦+中Rg1組、鈦+低Rg1組及正常組環(huán)氧化酶2mRNA的表達(dá)較弱[(0.734±0.065),(0.621±0.032),(0.517±0.042),(0.386±0.015),P=0.000,P=0.000,P=0.000,P=0.000]; 鈦+高、中、低Rg1組的表達(dá)均較正常組強(P=0.000,P=0.000,P=0.000); 鈦+低Rg1組較鈦+高、中Rg1組弱(P=0.000,P=0.000),鈦+中Rg1組較鈦+高Rg1組弱(P=0.000)。5組成骨細(xì)胞腫瘤壞死因子αmRNA表達(dá)的差異有統(tǒng)計學(xué)意義(F=1635.878,P=0.000); 與鈦微粒組(1.000±0.000)相比,鈦+高Rg1組、鈦+中Rg1組、鈦+低Rg1組及正常組腫瘤壞死因子αmRNA的表達(dá)較弱[(0.823±0.078),(0.764±0.107),(0.543±0.042),(0.399±0.047),P=0.000,P=0.000,P=0.000,P=0.000)]; 鈦+高、中、低Rg1組均較正常組強(P=0.000,P=0.000,P=0.000); 鈦+低Rg1組較鈦+高、中Rg1組弱(P=0.000,P=0.000); 鈦+高Rg1與鈦+中Rg1組比較,差異無統(tǒng)計學(xué)意義(P=0.057)。5組成骨細(xì)胞中環(huán)氧化酶2蛋白表達(dá)的差異有統(tǒng)計學(xué)意義(F=886.930,P=0.000); 與鈦微粒組(0.854±0.067)相比,鈦+高Rg1組、鈦+中Rg1組、鈦+低Rg1組及正常組環(huán)氧化酶2蛋白的表達(dá)較弱[(0.774±0.045),(0.634±0.054),(0.433±0.032),(0.304±0.058),P=0.000,P=0.000,P=0.000,P=0.000]; 鈦+高、中、低Rg1組均較正常組強(P=0.000,P=0.000,P=0.000); 鈦+高Rg1組較鈦+中Rg1組、鈦+低Rg1組強(P=0.010,P=0.000); 鈦+中Rg1組較鈦+低Rg1組強(P=0.002)。結(jié)論:成骨細(xì)胞與鈦微粒共培養(yǎng)后,鈦微粒能促進(jìn)成骨細(xì)胞分泌炎癥因子,人參皂甙Rgl干預(yù)可減弱鈦微粒對成骨細(xì)胞的刺激、抑制炎癥因子的表達(dá),這可能是人參皂甙Rgl抑制假體周圍骨吸收,防治人工關(guān)節(jié)假體松動的作用機(jī)制。但人參皂甙Rg1對成骨細(xì)胞產(chǎn)生影響的具體作用機(jī)制及藥物劑量效應(yīng)關(guān)系還有待進(jìn)一步研究。
Abstract:
Objective:To observe the effect of ginsenoside Rg1 and titanium(Ti)particles on rat cranioaural osteoblasts,so as to provide new preventive treatment of joint prosthesis loosening.Methods:The cranioaural osteoblasts were collected from the newborn SD rats and were purified.The Ti particles were screened and the leaching liquor of Ti were prepared.After the endotoxin detection,the third-generation osteoblasts were cultured in Dulbecco's Modified Eagle Medium(DMEM)supplemented with 10% fetal bovine serum(normal group),DMEM supplemented with 10% fetal bovine serum and 0.1%(volume ratio)Ti particles suspension(Ti particles group),DMEM supplemented with 10% fetal bovine serum and 0.1% Ti particles suspension and Ginsenoside Rg1 with final concentration of 100 μg/mL(Ti+high Rg1 group),DMEM supplemented with 10% fetal bovine serum and 0.1% Ti particles suspension and Ginsenoside Rg1 with final concentration of 50 μg/mL(Ti+middle Rg1 group),DMEM supplemented with 10% fetal bovine serum and 0.1% Ti particles suspension and Ginsenoside Rg1 with final concentration of 25 μg/mL(Ti+low Rg1 group),one hundred thousand osteoblasts in one milliliter of culture solutions.The osteoblasts were cultured for 24 hours continuously and then the shape of them were observed.The concentration of prostaglandin E2(PGE-2),tumor necrosis factor-α(TNF-α),interleukin-6(IL-6),interleukin-1(IL-1)and interleukin 1 receptor antagonist protein(IL-1ra)in the culture solution were detected through enzyme-linked immunoadsordent assay(ELISA).The expression of cyclooxygenase 2(COX-2)mRNA and TNF-α mRNA in the osteoblasts were detected through real-time fluorescence quantitative polymerase chain reaction,and the expression of COX-2 protein in the osteoblasts were detected through Western Blotting.Results:There were statistical differences in the optical density(OD)values of PGE-2 among the 5 groups(F=244.895,P=0.000).The OD values of PGE-2 were higher in Ti particles group(53.362±0.307),Ti+high Rg1 group(41.048±0.431)and Ti+middle Rg1 group(38.998±0.234)compared to normal group(31.687±0.466),there were statistical differences between them(P=0.000,P=0.000,P=0.000).The OD values of PGE-2 were lower in Ti+high Rg1 group,Ti+middle Rg1 group and Ti+low Rg1 group(32.501±0.124)compared to Titanium particles group(P=0.000,P=0.000,P=0.000).The OD values of PGE-2 were lower in Ti+low Rg1 group compared to Ti+high Rg1 group and Ti+middle Rg1 group respectively(P=0.000,P=0.000).The OD values of PGE-2 were higher in Ti+high Rg1 group compared to Ti+middle Rg1 group(P=0.000).There were no statistical differences in the OD values of PGE-2 between normal group and Ti+low Rg1 group(P=0.168).There were statistical differences in the OD values of TNF-α among the 5 groups(F=72.340,P=0.000).The OD values of TNF-α were higher in Ti particles group,Ti+high Rg1 group,Ti+middle Rg1 group and Ti+low Rg1 group compared to normal group((50.121±0.532),(49.675±0.336),(46.431±0.245),(42.521±0.513),(40.055±0.471),P=0.000,P=0.000,P=0.000,P=0.001).The OD values of TNF-α were lower in Ti+middle Rg1 group and Ti+low Rg1 group compared to Ti particles group(P=0.000,P=0.000).The OD values of TNF-α were lower in Ti+low Rg1 group compared to Ti + high Rg1 group and Ti+middle Rg1 group respectively(P=0.000,P=0.000).The OD values of TNF-α were higher in Ti + high Rg1 group compared to Ti+middle Rg1 group(P=0.000).There were no statistical differences in the OD values of TNF-α between Ti particles group and Ti+high Rg1 group(P=0.230).There were statistical differences in the OD values of IL-6 among the 5 groups(F=80.449,P=0.000).The OD values of IL-6 were higher in Ti particles group,Ti+high Rg1 group,Ti+middle Rg1 group and Ti+low Rg1 group compared to normal group((80.537±0.883),(70.975±0.945),(68.154±0.745),(63.335±0.845),(57.550±0.610),P=0.000,P=0.000,P=0.000,P=0.000).The OD values of IL-6 were lower in Ti+high Rg1 group,Ti+middle Rg1 group and Ti+low Rg1 group compared to Ti particles group(P=0.000,P=0.000,P=0.000).The OD values of IL-6 were lower in Ti+low Rg1 group compared to Ti+high Rg1 group and Ti+middle Rg1 group respectively(P=0.001,P=0.000).The OD values of IL-6 were higher in Ti+high Rg1 group compared to Ti+middle Rg1 group(P=0.039).There were statistical difference in the OD values of IL-1 among the 5 groups(F=38.483,P=0.000).The OD values of IL-1 were higher in Ti particles group,Ti+high Rg1 group,Ti+middle Rg1 group and Ti+low Rg1 group compared to normal group((83.106±4.413),(59.506±1.294),(56.881±3.561),(45.081±3.459),(37.579±3.526),P=0.000,P=0.000,P=0.000,P=0.000).The OD values of IL-1 were lower in Ti+high Rg1 group,Ti+middle Rg1 group and Ti+low Rg1 group compared to Ti particles group(P=0.000,P=0.000,P=0.000).The OD values of IL-1 were lower in Ti+low Rg1 group compared to Ti+high Rg1 group and Ti+middle Rg1 group respectively(P=0.000,P=0.000).There were no statistical differences in the OD values of IL-1 between Ti+middle Rg1 group and Ti+high Rg1 group(P=0.187).There were statistical differences in the OD values of IL-1ra among the 5 groups(F=492.724,P=0.000).The OD values of IL-1ra were lower in Ti particles group,Ti+high Rg1 group,Ti+middle Rg1 group and Ti + low Rg1 group compared to normal group((64.111±1.364),(116.351±5.432),(229.768±3.545),(207.203±2.436),(268.019±3.871),P=0.000,P=0.000,P=0.000,P=0.000).The OD values of IL-1ra were higher in Ti+high Rg1 group,Ti+middle Rg1 group and Ti+low Rg1 group compared to Ti particles group(P=0.000,P=0.000,P=0.000).The OD values of IL-1ra were higher in Ti+middle Rg1 group compared to Ti+high Rg1 group and Ti+low Rg1 group respectively(P=0.000,P=0.000).The OD values of IL-1ra were lower in Ti+high Rg1 group compared to Ti+low Rg1 group(P=0.000).The amplification curve of β-actin,COX-2 and TNF-α in fluorescent quantitation RT-PCR were shown as specific amplification and the genetic-solubility curve were shown as single peak.There were statistical differences in the expression of COX-2 mRNA among the 5 groups(F=886.930,P=0.000).Compared to Ti particles group,the expression of COX-2 mRNA were weaker in Ti+high Rg1 group,Ti+middle Rg1 group,Ti+low Rg1 group and normal group((0.734±0.065),(0.621±0.032),(0.517±0.042),(0.386±0.015),P=0.000,P=0.000,P=0.000,P=0.000).The expression of COX-2 mRNA were stronger in Ti+high Rg1 group,Ti+middle Rg1 group,Ti+low Rg1 group compared to normal group respectively(P=0.000,P=0.000,P=0.000).The expression of COX-2 mRNA were weaker in Ti+low Rg1 group compared to Ti+high Rg1 group and Ti+middle Rg1 group respectively(P=0.000,P=0.000).The expression of COX-2 mRNA were weaker in Ti+middle Rg1 group compared to Ti+high Rg1 group(P=0.000).There were statistical differences in the expression of TNF-α mRNA among the 5 groups(F=1 635.878,P=0.000).Compared to Ti particles group(1.000±0.000),the expression of TNF-α mRNA were weaker in Ti+high Rg1 group,Ti+middle Rg1 group,Ti+low Rg1 group and normal group((0.823±0.078),(0.764±0.107),(0.543±0.042),(0.399±0.047),P=0.000,P=0.000,P=0.000,P=0.000)).The expression of TNF-α mRNA were stronger in Ti+high Rg1 group,Ti+middle Rg1 group,Ti+low Rg1 group compared to normal group respectively(P=0.000,P=0.000,P=0.000).The expression of TNF-α mRNA were weaker in Ti+low Rg1 group compared to Ti+high Rg1 group and Ti+middle Rg1 group respectively(P=0.000,P=0.000).There were no statistical differences in the expression of TNF-α mRNA between Ti+high Rg1 group and Ti+middle Rg1 group(P=0.057).There were statistical differences in the expression of COX-2 protein among the 5 groups(F=886.930,P=0.000).Compared to Ti particles group(0.854±0.067),the expression of COX-2 protein were weaker in Ti+high Rg1 group,Ti+middle Rg1 group,Ti+low Rg1 group and normal group((0.774±0.045),(0.634±0.054),(0.433±0.032),(0.304±0.058),P=0.000,P=0.000,P=0.000,P=0.000).Compared to Ti+high Rg1 group,Ti+middle Rg1 group and Ti+low Rg1 group respectively,the expression of COX-2 protein was weaker in normal group(P=0.000,P=0.000,P=0.000).The expression of COX-2 protein were stronger in Ti+high Rg1 group compared to Ti+middle Rg1 group and Ti+low Rg1 group respectively(P=0.010,P=0.000).Ti+middle Rg1 group surpassed Ti+low Rg1 group(P=0.002).Conclusion:After co-cultured with Ti particles,the osteoblasts can secrete more inflammatory factors promoted by Ti particles.Ginsenoside Rgl can weaken the impact of Ti particles on osteoblasts and suppress the expression of inflammation factors,which may be considered as the mechanism of action for ginsenoside Rgl to suppress bone resorption around the prosthesis and to prevent joint prosthesis loosening.However,further studies are needed to define the concrete mechanisms of influence of ginsenoside Rg1 on the osteoblasts and to demonstrate the concrete dose-effect relationship.

參考文獻(xiàn)/References:

[1] Minoda Y,Kobayashi A,Sakawa A,et al.Wear particle analysis of highly crosslinked polyethylene isolated from a failed total hip arthroplasty[J].J Biomed Mater Res B Appl Biomater,86(2):501-505.
[2] Min BW,Song KS,Bae KC,et al.Second-generation cementless total hip arthroplasty in patients with osteonecrosis of thefemoral head[J].J Arthroplasty,2008,23(6):902-910.
[3] Landgraeber S,von Knoch M,Löer F,et al.Extrinsic and intrinsic pathways of apoptosis in aseptic loosening after total hipreplacement[J].Biomaterials,2008,29(24-25):3444-3450.
[4] Schmiedberg SK,Jones LC,Chang DH,et al.Extraction and characterization of metallic wear debris from total joint arthroplasty[J].Biomed Sci Instrum,2007,43:104-109.
[5] Pioletti DP,Takei H,Kwon SY,et al.The cytotoxic effect of titanium particles phagocytosed by osteoblasts[J].J Biomed Mater Res,1999,46(3):399-407.
[6] Lahera V,Goicoechea M,de Vinuesa SG,et al.Endothelial dysfunction,oxidative stress and inflammation in atherosclerosis:beneficialeffects of statins[J].Curr Med Chem,2007,14(2):243-248.
[7] 胡霞敏,嚴(yán)常開,胡先敏.人參皂苷Rg1對大鼠腦缺血再灌注損傷細(xì)胞凋亡的影響[J].中國臨床藥理學(xué)與治療學(xué),2006,20(1):192-196.
[8] Li YN,Wu YL,Jia ZH,et al.Interaction between COX-2 and iNOS aggravates vascular lesion and antagonistic effect of ginsenoside[J].J Ethnopharmacol,2008,119(2):305-311.
[9] Dickens DS,Kozielski R,Khan J,et al.Cyclooxygenase-2 expression in pediatric sarcomas[J].Pediatr Dev Pathol,2002,5(4):356-364.
[10] 韓建國,王麗,韓斐斐,等.老年牙周病患者牙槽骨吸收與IL-6、TNF-α、PGE-2水平相關(guān)性研究[J].徐州醫(yī)學(xué)院學(xué)報,2011,31(6):392-394.
[11] Crotti TN,Smith MD,Findlay DM,et al.Factors regulating osteoclast formation in human tissues adjacent to peri-implant bone loss:expression of receptor activator NFkappaB,RANK ligand and osteoprotegerin[J].Biomaterials,2004,25(4):565-573.
[12] 王海燕,鄧輝,徐春燕,等.脂多糖刺激單核巨噬細(xì)胞培養(yǎng)上清液對成骨細(xì)胞成骨特性的影響[J].中華口腔正畸學(xué)雜志,2011,18(2):92-96.
[13] 林蕾蕾,鄧輝,王海燕,等.炎癥狀態(tài)下張應(yīng)力對成骨細(xì)胞基質(zhì)金屬蛋白酶-13和金屬蛋白酶抑制因子-1表達(dá)的影響[J].中華口腔正畸學(xué)雜志,2012,19(2):92-95.
[14] 趙瑋,余占海,李秀蘭,等.人參皂甙Rg-1對牙周炎大鼠牙周組織中TNF-α、IL-1β表達(dá)的影響[J].口腔醫(yī)學(xué)研究,2009,25(5):548-550.
[15] Sun HQ,Zhou ZY.Effect of ginsenoside-Rg3 on the expression of VEGF and TNF-α in retina with diabetic rats[J].Int J Ophthalmol,2010,3(3):220-223.
[16] 石松林,李祺福,王國紅,等.人參皂甙Rg1對人成骨肉瘤MG-63細(xì)胞形態(tài)結(jié)構(gòu)和終末分化指標(biāo)的影響[J].廈門大學(xué)學(xué)報:自然科學(xué)版,2009,48(3):392-398.
[17] 宋娟,劉曉磊,何娟,等.川芎嗪和人參皂苷Rg1對Caco-2細(xì)胞P-糖蛋白功能和表達(dá)的影響[J].中國藥學(xué)雜志,2008,43(13):987-991.
[18] 劉黎軍,楊雷,肖建德,等.人參皂甙Rb1及Rg1對許旺細(xì)胞神經(jīng)生長因子表達(dá)的影響[J].中國組織工程與臨床康復(fù),2009,13(32):6393-6396.

備注/Memo

備注/Memo:
通訊作者:林煜 E-mail:[email protected] 基金項目:國家自然科學(xué)基金資助項目(81173282); 福建省科技廳重點項目(2009Y0028); 教育部博士點基金項目(200803930001)
更新日期/Last Update: 1900-01-01